EPISODE · Sep 8, 2024 · 18 MIN
ICT Ep15: Q2'24 The quarterly recap with Joel White (Part 3 of 3)
from Innovating Clinical Trials · host Liam Eves and Ted Trafford
Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.In today's session we chat with Joel White from Marketcap Consulting about the financial performance of the clinical development space. In the final part of our 3 part discussion we talk through book to bill ratios, find out what is concerning Joel with the market and dive deeper into the Walgreens and BARDA agreement.
Embed this episode
What this episode covers
Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom. In today's session we chat with Joel White from Marketcap Consulting about the financial performance of the clinical development space. In the final...
Ready to play
ICT Ep15: Q2'24 The quarterly recap with Joel White (Part 3 of 3)
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.